Understanding the components of the ion and water homeostatic pathways might lead to strategies aimed at controlling or reversing myelinic oedema for the treatment of CLCN2-related leucoencephalopathy and related genetic diseases. The gene discussed is CLCN2; the disease is hereditary disease.